Skip to main content
Clinical Trials/NCT05902442
NCT05902442Not yet recruitingNot Applicable

A Clinical Comparison of Patient-specific 3D Printed Splints Versus Conventional Splints in the Treatment of Distal Radius Fractures.

Radboud University Medical Center0 sites24 target enrollmentStarted: October 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
24
Primary Endpoint
CSD-OPUS

Study Overview

Brief Summary

The goal of this clinical trial is to assess patient reported outcome measures of adult patients who are diagnosed with a distal radius fracture and treated with a patient-specific 3D printed splint as compared to a control cohort.

Patients receive routine immobilization procedure with a patient-specific 3D printed splint instead of the use of a conventional forearm splint after one week of conventional immobilization.

The main study parameters are patient reported outcome measures related to comfort and satisfaction of the medical aid. This will be measured qualitatively with a semi-structured interview and quantitively using questionnaires.

Detailed Description

Distal radius fracture (DRF) is a very common injury of the upper extremity. Yearly, over 45,000 patients visit the outpatient clinic with a DRF in the Netherlands. One third of these fractures are non-displaced and two thirds are displaced fractures. The conservative treatment of DRFs includes immobilization of the injured extremity using a conventional forearm cast. These casts do cause all sorts of discomfort during wear and impose life-style restrictions on the wearer. Examples are irritation and itching of the skin, pain from pressure points and inability to shower or swim without a protective sleeve. Emergent three-dimensional (3D) technology enables patient-specific splint design and fabrication. These splints are custom made to accurately fit the individual patient. The material of 3D printed splints is considered lightweight. Moreover, 3D splint design allows an open structure resulting in more ventilation, offering better hygiene and the possibility for wound control. The production of 3D splints can be accomplished with several hardware and software combination. The production process is similar overall and requires several steps. First image data with 3D spatial information of the limb is captured with either a 3D scanner or medical imaging device. The design of the 3D printed splint is further developed using a software application. The 3D splints design data is then exported, and the physical splint is printed using a 3D printer. Depending on material and device characteristics, postprocessing steps are required. The splint may require removal of support, curing and smoothing. If applicable, a closure mechanism is applied.

Currently most implementations of custom made 3D printed splints happen within the framework of case series or feasibility studies. Some previous studies have described on clinical tests from patients with promising results. However, studies are heterogenous in the use of hardware, software, 3D splint design, print materials, fabrication time and costs. Moreover, clinical comparison with conventional interventions remain scare. Therefore, it is challenging to determine the impact of 3D printed splints intervention on the patient with injuries .

The goal of this clinical trial is to assess patient reported outcome measures of adult patients who are diagnosed with a DRF and treated with a patient- specific 3D printed splint as compared to a control cohort. The secondary objectives are:

  • To define whether treatment of 3D printed splints of DRF's result in the same clinical outcomes compared to treatment with standard plaster cast .
  • To investigate the safety of 3D printed splint treatment.
  • To generate hypothesis which individual characteristics might be used to determine which patients can benefit most from 3D printed splint treatment.
  • To investigate barriers and facilitators to implementation.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 16 years or older
  • Admitted to the emergency department or plaster room with a DRF
  • Non-operative treatment with cast immobilization
  • Written informed consent
  • Patients must be able to follow the study protocol

Exclusion Criteria

  • Operative treatment
  • Open fractures
  • History of surgically treated wrist fracture on the currently injured side within the last year (≤ 1 year)
  • Unable to wear conventional forearm splint due to medical condition, known allergies or other reasons
  • (partially) paralysis of the affected arm
  • DRF older than two weeks

Outcomes

Primary Outcomes

CSD-OPUS

Time Frame: three to five weeks post injury

The Orthotics and Prosthetics User's Survey on the Satisfaction with Devices.

EQ-5D VAS

Time Frame: three to five weeks post injury

Rates the overall health of a patient.

D-QUEST

Time Frame: three to five weeks post injury

Instrument for measuring client satisfaction with a medical device. D-QUEST is a Dutch version of the Quebec User Evalutation of Satisfaction with assistive Technology.

Semi structured interview

Time Frame: three to five weeks post injury

Patient reported outcome measrues related to comfort and satisfaction of the medical aid. Issures discussed:limitations daily life, cosmetic look and local complicaitons.

Secondary Outcomes

  • Complications(three months post injury.)
  • Barriers to implementation(one week to three months post injury)
  • PRWE(Approximately, one week, three to five weeks and 3 months post injury.)
  • Union rate(One week to three months post injury)
  • Safety outcomes(one week to three months post injury)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

A Clinical Comparison of Patient-specific... | Clinical Trial